DE1525541U - - Google Patents

Info

Publication number
DE1525541U
DE1525541U DENDAT1525541D DE1525541DU DE1525541U DE 1525541 U DE1525541 U DE 1525541U DE NDAT1525541 D DENDAT1525541 D DE NDAT1525541D DE 1525541D U DE1525541D U DE 1525541DU DE 1525541 U DE1525541 U DE 1525541U
Authority
DE
Germany
Prior art keywords
iwt
dwr
becomes
bwi
diw
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1525541D
Other languages
German (de)
English (en)
Publication of DE1525541U publication Critical patent/DE1525541U/de
Active legal-status Critical Current

Links

Landscapes

  • Developing Agents For Electrophotography (AREA)
  • Exhaust Gas After Treatment (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DENDAT1525541D Active DE1525541U (cg-RX-API-DMAC7.html)

Publications (1)

Publication Number Publication Date
DE1525541U true DE1525541U (cg-RX-API-DMAC7.html)

Family

ID=826748

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1525541D Active DE1525541U (cg-RX-API-DMAC7.html)

Country Status (1)

Country Link
DE (1) DE1525541U (cg-RX-API-DMAC7.html)

Similar Documents

Publication Publication Date Title
Forna et al. Interventions for treating trichomoniasis in women
Chesney Adherence to HAART regimens
Eaton et al. Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies
Campbell et al. Sclerosing peritonitis: identification of diagnostic, clinical, and radiological features
Hoenig et al. The nosological position of transsexualism
DE1525541U (cg-RX-API-DMAC7.html)
Gotuzzo et al. Ciprofloxacin for the treatment of cholera: a randomized, double-blind, controlled clinical trial of a single daily dose in Peruvian adults
Cao et al. Sodium-glucose cotransporter 2 inhibitors benefit to kidney and cardiovascular outcomes for patients with type 2 diabetes mellitus and chronic kidney disease 3b-4: A systematic review and meta-analysis of randomized clinical trials
Maibach Glutaraldehyde: cross-reactions to formaldehyde?
Groop et al. Treatment strategies for secondary sulfonylurea failure. Should we start insulin or add metformin? Is there a place for intermittent insulin therapy?
Mackay et al. Failure of lithium treatment in established tardive dyskinesia
Powers et al. Activity of two chlorinated lincomycin analogues against chloroquine-resistant falciparum malaria in owl monkeys
Angulo et al. A phase 2b, dose-selection study evaluating the efficacy and safety of oral ibrexafungerp vs fluconazole in vulvovaginal candidiasis (DOVE)
Walker et al. A multicentre study comparing mazindol and placebo in obese patients
Cohen et al. A comparative study of streptomycin and dihydrostreptomycin in pulmonary tuberculosis
CA2246407A1 (en) Use of inhibitors of the sodium-hydrogen exchanger for the production of a pharmaceutical for the treatment of disorders which are caused by protozoa
ELLIS-PEGLER The effects of World Health Organization chemotherapy on imported leprosy in Auckland, New Zealand, 1983-90
Niang et al. Controlled Trial of 3-Day
Llende et al. Effect of splenectomy on Trypanosoma lewisi infection in young rats
Leroy et al. 272-PA12 Survival of HIV-infected patients after tuberculosis, Bordeaux, France, 1988–1994
Nesher et al. Recommendations for drug therapy of rheumatoid arthritis in elderly patients
COHEN Ground AIDS Zero: Research in Africa
Shabuj et al. Gentamicin in newborn sepsis: Once daily dose versus twice daily dose
Weaver Prehospital thrombolysis in myocardial infarction
Kersh et al. P693 Neisseria gonorrhoeae in-vitro susceptibilities to ceftriaxone, cefixime and azithromycin in GISP isolates, 1987–2017